期刊
CELL REPORTS PHYSICAL SCIENCE
卷 1, 期 2, 页码 -出版社
CELL PRESS
DOI: 10.1016/j.xcrp.2020.100014
关键词
-
类别
资金
- NYU Abu Dhabi
- Al Jalila Foundation Research Center seed grant [AJF201624]
- NYU
- Stockholm University
Amyloid proteins and peptides are a major contributing factor to the development of various neurodegenerative disorders, including Alzheimer's and prion diseases. Previously, a designed cell-penetrating peptide (CPP) comprising a hydrophobic signai sequence followed by a prion protein (PrP)-derived polycationic sequence (PrP23-28: KKRPKP) was shown to have potent anti-prion properties. Here, we extend this approach toward the amyloid-beta (A beta) peptide amyloid formation, which is associated with Alzheimer's disease. We characterized the interactions of the CPP with A beta using complementary in vitro and in silico experiments. We report that the CPP stabilizes A beta in a non-amyloid state and inhibits A beta-induced neurotoxicity. Moreover, replacing PrP23-28 with a corresponding segment from A beta results in a construct with similar CPP functionality and antagonism of A beta aggregation and neurotoxicity. Our findings reveal a general underlying principle for inhibition of pathogenic protein aggregation that may facilitate the design of CPP-based therapeutics for amyloid diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据